Nar Cancer

Journal Title：Nar Cancer

The original intention of the founding of Nar Cancer was to provide a high-level communication platform for scholars in the fields of nucleic acid research and cancer research, and to promote cooperation and integration between the two fields. The editor in chief, Professor William S. Dynan, comes from Emory University School of Medicine in the United States, which has laid a solid foundation for the academic orientation and development strategy of the journal. This journal mainly publishes original research, investigation, and summary articles in the interdisciplinary field of nucleic acid research and cancer research, covering cancer computational biology, cancer data resources, DNA damage sensing and repair, gene regulation and chromosome, genomics, methodology, nucleic acid based cancer therapy, and structural biology of cancer-related macromolecules. The publication of these contents not only enriches the theoretical system of cancer research, but also provides important references and guidance for clinical practice.

In summary, Nar Cancer is an academic journal with significant influence in the interdisciplinary field of nucleic acid research and cancer, providing a high-level communication platform for scholars worldwide and promoting cooperation and integration between the two fields.

《癌症杂志》的创刊初衷是为核酸研究和癌症研究领域的学者提供一个高水平的交流平台，推动两个领域间的合作与融合。其主编William S. Dynan教授来自美国埃默里大学医学院，这一背景为杂志的学术导向和发展战略奠定了坚实的基础。该杂志主要发表核酸研究与癌症研究交叉领域的原创研究、调查及总结性文章，涵盖了癌症计算生物学、癌症数据资源、DNA损伤感应与修复、基因调控与染色体、基因组学、方法学、基于核酸的癌症治疗以及癌症相关大分子的结构生物学等多个方面。这些内容的发表，不仅丰富了癌症研究的理论体系，也为临床实践提供了重要的参考和指导。

总之《Nar Cancer》杂志是一本在核酸研究与癌症领域交叉学科中具有重要影响力的学术期刊，为全球学者提供了一个高水平的交流平台，推动了两个领域间的合作与融合。

Nar Cancer由Oxford University Press出版商出版，收稿方向涵盖Medicine - Oncology全领域，平均审稿速度 13 Weeks ，影响因子指数3.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。